<!--
  ~ DREIMT Frontend
  ~
  ~  Copyright (C) 2018-2019 - Hugo López-Fernández,
  ~  Daniel González-Peña, Miguel Reboiro-Jato, Kevin Troulé,
  ~  Fátima Al-Sharhour and Gonzalo Gómez-López.
  ~
  ~  This program is free software: you can redistribute it and/or modify
  ~  it under the terms of the GNU General Public License as published by
  ~  the Free Software Foundation, either version 3 of the License, or
  ~  (at your option) any later version.
  ~
  ~  This program is distributed in the hope that it will be useful,
  ~  but WITHOUT ANY WARRANTY; without even the implied warranty of
  ~  MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
  ~  GNU General Public License for more details.
  ~
  ~  You should have received a copy of the GNU General Public License
  ~  along with this program. If not, see <http://www.gnu.org/licenses/>.
  -->

<div id="main-content">
  <div id="welcome">
    <h2>Welcome to</h2>
    <img src="../../../../../assets/images/logo.svg" alt="DREIMT"/>
    <div>A tool for immune modulation drug prioritization</div>
    <button mat-button (click)="onNavigateToDrugPrioritization()"
            matTooltip="Opens a query panel to get drug prioritizations for a custom signature or geneset.">
      Drug prioritization
    </button>
    <button mat-button (click)="onNavigateToSignaturesComparison()"
            matTooltip="Opens a query panel to find similar signatures or geneset in the database to a custom signature or geneset by calculating the Jaccard index.">
      Signatures comparison
    </button>
    <button mat-button (click)="onNavigateToDatabase()"
            matTooltip="Opens the view to explore the database of calculated drug prioritizations.">
      Database
    </button>
  </div>

  <div id="what-is-dreimt">
    <h3>What is DREIMT?</h3>
    <p>
      DREIMT is a bioinformatics tool for hypothesis generation and <strong>prioritization of drugs capable of
      modulating immune cells activity</strong>. The current version integrates
      <strong>{{stats.signaturesCount}}</strong> immune cell signatures and <strong>{{stats.drugCount}}</strong>
      compound profiles.
    </p>

    <p>
      DREIMT accepts users own immune cell signature for drug prioritization.
    </p>
    <mat-nav-list role="navigation" dense>
      <a mat-list-item [routerLink]="sample.route" [queryParams]="sample.queryParams" *ngFor="let sample of SAMPLES">{{sample.title}}</a>
    </mat-nav-list>
  </div>

  <div id="home-image-container">
    <img src="../../../../../../../assets/images/home-dreimt.png" alt="How it works?">
  </div>
</div>
